Product Information
Name:Tarlox-TKI
Brand:Biosynth
Description:Tarlox-TKI is a drug with potential anti-cancer activity, which acts as a selective inhibitor of the enzyme P2Y receptor. It binds to the α7 nicotinic acetylcholine receptor, preventing neuronal death and skin cancer. Tarlox-TKI has been shown to inhibit xenograft tumor growth in mice and also suppresses transcriptional regulation of genes involved in autoimmune diseases. Tarlox-TKI interacts with toll-like receptor 4 (TLR4) and inhibits the expression of the gene 2-aminoethoxydiphenyl borate (APBD). Tarlox-TKI prevents p21 from becoming activated by inhibiting polymerase chain reaction (PCR), which leads to inhibition of leukemia inhibitory factor (LIF).
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:461.7 g/mol
Formula:C19H18BrClN6O
Purity:Min. 95%
Technical inquiry about: Tarlox-TKI
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.